研究单位：[1]Zhejiang Kanglaite Pharmaceutical Co.Ltd.[2]Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei 430030,P.R.China[3]H & J CRO International,Inc.
研究目的：
The purpose of the study is to explore the efficacy and safety of Kanglaite Injection in the treatment of patients with late-stage cancer cachexia.
